Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (15495) 15495
Publication (977) 977
Book / eBook (597) 597
Newsletter (214) 214
Newspaper Article (210) 210
Book Review (113) 113
Magazine Article (41) 41
Book Chapter (34) 34
Conference Proceeding (13) 13
Dissertation (8) 8
Trade Publication Article (4) 4
Paper (3) 3
Data Set (2) 2
Government Document (2) 2
Reference (2) 2
Report (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (14390) 14390
female (8667) 8667
male (7676) 7676
middle aged (6490) 6490
index medicus (5340) 5340
adult (5053) 5053
heart neoplasms - surgery (4954) 4954
aged (4444) 4444
surgery (4256) 4256
cardiac & cardiovascular systems (3475) 3475
heart neoplasms - diagnosis (2956) 2956
heart (2461) 2461
heart neoplasms - pathology (2387) 2387
echocardiography (2205) 2205
treatment outcome (2033) 2033
heart neoplasms - diagnostic imaging (1930) 1930
myxoma - surgery (1888) 1888
heart neoplasms - complications (1807) 1807
oncology (1731) 1731
cancer (1672) 1672
tumors (1585) 1585
diagnosis, differential (1536) 1536
heart atria (1513) 1513
diagnosis (1369) 1369
tomography, x-ray computed (1332) 1332
risk factors (1291) 1291
respiratory system (1285) 1285
follow-up studies (1229) 1229
adolescent (1165) 1165
care and treatment (1137) 1137
myxoma - diagnosis (1131) 1131
retrospective studies (1109) 1109
mortality (1102) 1102
aged, 80 and over (1009) 1009
research (989) 989
patients (965) 965
heart atria - pathology (954) 954
heart diseases (947) 947
heart atria - surgery (917) 917
magnetic resonance imaging (901) 901
child (893) 893
heart neoplasms - secondary (878) 878
echocardiography, transesophageal (868) 868
electrocardiography (853) 853
health aspects (851) 851
prognosis (837) 837
abridged index medicus (834) 834
chemotherapy (812) 812
medicine & public health (795) 795
cardiovascular system (772) 772
myxoma - complications (745) 745
time factors (745) 745
myxoma (730) 730
cardiology (728) 728
lung neoplasms - surgery (724) 724
medicine (712) 712
cardiac surgical procedures (706) 706
myxoma - diagnostic imaging (680) 680
breast cancer (679) 679
cardiovascular diseases (679) 679
medicine, general & internal (677) 677
heart failure (652) 652
metastasis (651) 651
radiology, nuclear medicine & medical imaging (650) 650
myxoma - pathology (639) 639
fatal outcome (635) 635
infant (626) 626
radiotherapy (624) 624
analysis (613) 613
pathology (611) 611
transplantation (606) 606
risk (589) 589
ultrasonography (586) 586
therapy (581) 581
cardiovascular disease (577) 577
fibroma - surgery (571) 571
heart ventricles (567) 567
child, preschool (542) 542
diseases (540) 540
heart atria - diagnostic imaging (536) 536
lung cancer (534) 534
case report (529) 529
heart neoplasms (529) 529
cardiopulmonary bypass (522) 522
management (518) 518
neoplasm invasiveness (515) 515
heart attacks (512) 512
heart surgery (510) 510
animals (501) 501
pediatrics (497) 497
infant, newborn (492) 492
cardiac surgical procedures - methods (488) 488
disease (481) 481
research article (470) 470
young adult (464) 464
neoplasms (459) 459
thoracic surgery (456) 456
anesthesiology (455) 455
breast neoplasms - radiotherapy (447) 447
prospective studies (446) 446
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (493) 493
Collection Dvlpm't (Acquisitions) - Closed Orders (21) 21
Collection Dvlpm't (Acquisitions) - Vendor file (18) 18
Scarborough Hospital - General (12) 12
St. Michael's Hospital - Stacks (12) 12
Humber River Regional Hospital - Church Stacks (10) 10
Lakeridge Health Sciences - Oshawa (8) 8
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (8) 8
Providence Healthcare - Stacks (7) 7
Toronto East General Hospital - Stacks (7) 7
Humber River Regional Hospital - Finch Stacks (6) 6
Trillium Health Centre - Stacks (6) 6
UofT at Mississauga - Stacks (6) 6
Online Resources - Online (5) 5
Providence Healthcare - Reference (5) 5
Scarborough Hospital - Birchmount (5) 5
Credit Valley Hospital - Stacks (4) 4
Gerstein Science - Circulation Desk (3) 3
Markham Stouffville Hospital - Stacks (3) 3
New College (Ivey) - Stacks (3) 3
Toronto East General Hospital - Reference (3) 3
Credit Valley Hospital - Reference (2) 2
Holland Bloorview Kids Rehabilitation - Stacks (2) 2
Humber River Regional Hospital - Stacks (2) 2
Law (Bora Laskin) - Stacks (2) 2
OISE - Stacks (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Reference (2) 2
UTL at Downsview - May be requested (2) 2
West Park Healthcare Centre - Hospital Department (2) 2
West Park Healthcare Centre - Stacks (2) 2
Church Stacks (1) 1
Credit Valley Hospital - Online (1) 1
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (1) 1
Finch Stacks (1) 1
Gerstein Science - Missing (1) 1
Gerstein Science - Reference (1) 1
Humber River Regional Hospital - Finch Reference (1) 1
Lakeridge Health Sciences - Online (1) 1
Providence Healthcare - Reserve desk (1) 1
Scarborough Hospital - Hospital Department (1) 1
Scarborough Hospital - Missing (1) 1
St Josephs Health Centre - Reference (1) 1
St Josephs Health Centre - Stacks (1) 1
St. Augustine's Seminary - Stacks (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
St. Michael's Hospital - Online (1) 1
Stacks (1) 1
Sunnybrook Health Sciences Centre - Online (1) 1
Toronto East General Hospital - Online (1) 1
Toronto East General Hospital - Pharmacy (1) 1
Trinity College (John W Graham) - Stacks (1) 1
UofT at Mississauga - Oversize (1) 1
UofT at Mississauga - Reference (1) 1
UofT at Scarborough - Stacks (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
Victoria University Emmanuel College - Stacks (1) 1
West Park Healthcare Centre - Pharmacy (1) 1
Women's College Hospital - Online (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (14379) 14379
Japanese (585) 585
French (375) 375
German (322) 322
Spanish (217) 217
Russian (184) 184
Italian (125) 125
Chinese (102) 102
Portuguese (92) 92
Polish (64) 64
Czech (26) 26
Turkish (24) 24
Dutch (22) 22
Hungarian (22) 22
Danish (17) 17
Serbian (13) 13
Croatian (10) 10
Romanian (10) 10
Swedish (10) 10
Norwegian (9) 9
Hebrew (6) 6
Korean (5) 5
Arabic (4) 4
Finnish (4) 4
Bulgarian (3) 3
Lithuanian (3) 3
Slovak (3) 3
Bosnian (2) 2
Ukrainian (2) 2
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial
by Nordlinger, Bernard, Prof and Sorbye, Halfdan, MD and Glimelius, Bengt, Prof and Poston, Graeme J, MD and Schlag, Peter M, Prof and Rougier, Philippe, Prof and Bechstein, Wolf O, Prof and Primrose, John N, Prof and Walpole, Euan T, MD and Finch-Jones, Meg, MD and Jaeck, Daniel, MD and Mirza, Darius, MD and Parks, Rowan W, MD and Collette, Laurence, PhD and Praet, Michel, ScD and Bethe, Ullrich, MD and Van Cutsem, Eric, MD and Scheithauer, Werner, MD and Gruenberger, Thomas, Prof and AGITG and Canc Res UK and FFCD and EORTC Gastrointestinal Tract Canc and ALM-CAO and Cancer Research UK and Fédération Francophone de Cancérologie Digestive (FFCD) and Arbeitsgruppe Lebermetastasen und-tumoren in der Chirurgischen Arbeitsgemeinschaft Onkologie (ALM-CAO) and Australasian Gastro-Intestinal Trials Group (AGITG) and EORTC Gastro-Intestinal Tract Cancer Group and Medicinska fakulteten and Medicinska och farmaceutiska vetenskapsområdet and Institutionen för onkologi, radiologi och klinisk immunologi and Uppsala universitet
Lancet, The, ISSN 0140-6736, 2008, Volume 371, Issue 9617, pp. 1007 - 1016
Summary Background Surgical resection alone is regarded as the standard of care for patients with liver metastases from colorectal cancer, but relapse is... 
Internal Medicine | ADJUVANT CHEMOTHERAPY | COLON-CANCER | 5-FLUOROURACIL | MEDICINE, GENERAL & INTERNAL | LEUCOVORIN | HEPATIC ARTERIAL INFUSION | PLUS IRINOTECAN | OXALIPLATIN | SURGICAL RESECTION | FOLINIC ACID | FLUOROURACIL | Humans | Middle Aged | Liver Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Liver Neoplasms - surgery | Male | Combined Modality Therapy | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Perioperative Care - methods | Adult | Female | Aged | Colorectal Neoplasms - pathology | Liver Neoplasms - secondary | Chemotherapy | Care and treatment | Colorectal cancer | Leucovorin | Dosage and administration | Excision (Surgery) | Metastasis | Methods | Fluorouracil | Cancer | Heart failure | Hospitals | Medical treatment | Mortality | Liver | Risk | Histology | Angina pectoris | Cancer surgery | Index Medicus | Abridged Index Medicus | Antineoplastic Combined Chemotherapy Protocols/adverse effects/therapeutic use | Medical and Health Sciences | Medicin och hälsovetenskap | Colorectal Neoplasms/pathology | Liver Neoplasms/drug therapy/secondary/surgery | MEDICINE | MEDICIN | Organoplatinum Compounds/administration & dosage | Perioperative Care/methods | Fluorouracil/administration & dosage
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Long-Term Results of Surgery for Small Intestinal Neuroendocrine Tumors at a Tertiary Referral Center
by Norlén, Olov and Stålberg, Peter and Öberg, Kjell and Eriksson, John and Hedberg, Jakob and Hessman, Ola and Janson, Eva Tiensuu and Hellman, Per and Åkerström, Göran and Medicinska fakulteten and Medicinska och farmaceutiska vetenskapsområdet and Gastrointestinalkirurgi and Uppsala universitet and Endokrinkirurgi and Institutionen för medicinska vetenskaper and Institutionen för kirurgiska vetenskaper
World Journal of Surgery, ISSN 0364-2313, 6/2012, Volume 36, Issue 6, pp. 1419 - 1431
Small intestinal neuroendocrine tumors (SI-NETs) are uncommon, with an annual incidence of about 1 per 100,000 individuals. The primary tumor (PT) is generally... 
Medicine & Public Health | Cardiac Surgery | Surgery | Abdominal Surgery | Vascular Surgery | Thoracic Surgery | General Surgery | LIVER METASTASES | SURVIVAL | SURGERY | INTERFERON | MANAGEMENT | NEURO ENDOCRINE TUMORS | PROGNOSTIC-FACTORS | MIDGUT CARCINOID-TUMORS | PERITONEAL CARCINOMATOSIS | COMBINATION | SURGICAL-TREATMENT | Lymph Node Excision | Multivariate Analysis | Prognosis | Follow-Up Studies | Intestine, Small - pathology | Humans | Middle Aged | Male | Liver Neoplasms - therapy | Liver Neoplasms - mortality | Female | Retrospective Studies | Liver Neoplasms - secondary | Peritoneal Neoplasms - secondary | Neuroendocrine Tumors - pathology | Intestinal Neoplasms - surgery | Intestinal Neoplasms - mortality | Peritoneal Neoplasms - surgery | Liver Neoplasms - surgery | Combined Modality Therapy | Lymphatic Metastasis | Peritoneal Neoplasms - mortality | Intestinal Neoplasms - pathology | Intestinal Neoplasms - therapy | Intestine, Small - surgery | Neuroendocrine Tumors - mortality | Survival Analysis | Neuroendocrine Tumors - surgery | Aged | Neuroendocrine Tumors - therapy | Laparotomy | Peritoneal Neoplasms - therapy | Liver cancer | Metastasis | Heart diseases | Health aspects | Coronary heart disease | Analysis | Clinical Medicine | Medical and Health Sciences | Cancer and Oncology | Klinisk medicin | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Risk of second primary lung cancer in women after radiotherapy for breast cancer
by Grantzau, Trine and Thomsen, Mette Skovhus and Væth, Michael and Overgaard, Jens
Radiotherapy and Oncology, ISSN 0167-8140, 2014, Volume 111, Issue 3, pp. 366 - 373
Abstract Background Several epidemiological studies have reported increased risks of second lung cancers after breast cancer irradiation. In this study we... 
Hematology, Oncology and Palliative Medicine | Radiotherapy | Second lung cancer | Breast cancer | SURVIVAL | TAMOXIFEN | POSTOPERATIVE RADIOTHERAPY | CHEMOTHERAPY | IRRADIATION | HEART-DISEASE | SOLID CANCERS | ONCOLOGY | COOPERATIVE GROUP DBCG | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | PULMONARY-FIBROSIS | Breast Neoplasms - surgery | Humans | Middle Aged | Neoplasms, Radiation-Induced - etiology | Risk | Case-Control Studies | Neoplasms, Second Primary - epidemiology | Neoplasms, Second Primary - etiology | Breast Neoplasms - radiotherapy | Lung Neoplasms - epidemiology | Lung Neoplasms - etiology | Denmark - epidemiology | Adult | Female | Aged | Neoplasms, Radiation-Induced - epidemiology | Breast Neoplasms - epidemiology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text 6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial
by Pivot, Xavier, Prof and Romieu, Gilles, MD and Debled, Marc, MD and Pierga, Jean-Yves, Prof and Kerbrat, Pierre, Prof and Bachelot, Thomas, MD and Lortholary, Alain, MD and Espié, Marc, MD and Fumoleau, Pierre, Prof and Serin, Daniel, MD and Jacquin, Jean-Philippe, MD and Jouannaud, Christelle, MD and Rios, Maria, MD and Abadie-Lacourtoisie, Sophie, MD and Tubiana-Mathieu, Nicole, Prof and Cany, Laurent, MD and Catala, Stéphanie, MD and Khayat, David, Prof and Pauporté, Iris, PhD and Kramar, Andrew, PhD and PHARE Trial Investigators and PHARE trial investigators
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 8, pp. 741 - 748
Summary Background Since 2005, 12 months of adjuvant trastuzumab has been the standard treatment for patients with HER2-positive early-stage breast cancer.... 
Hematology, Oncology and Palliative Medicine | ONCOLOGY | FOLLOW-UP | CHEMOTHERAPY | Breast Neoplasms - surgery | Predictive Value of Tests | Breast Neoplasms - secondary | Receptor, ErbB-2 - genetics | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Antineoplastic Agents - administration & dosage | Protein Kinase Inhibitors - adverse effects | Young Adult | Breast Neoplasms - chemistry | Antibodies, Monoclonal, Humanized - administration & dosage | Neoplasms, Second Primary | Time Factors | Antineoplastic Agents - adverse effects | Aged, 80 and over | Mastectomy | Adult | Female | Chemotherapy, Adjuvant | France | Heart Diseases - chemically induced | Radiotherapy, Adjuvant | Antibodies, Monoclonal, Humanized - adverse effects | Drug Administration Schedule | Early Detection of Cancer | Kaplan-Meier Estimate | Neoplasm Recurrence, Local | Proportional Hazards Models | Treatment Outcome | Breast Neoplasms - drug therapy | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Breast Neoplasms - genetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - mortality | Aged | Infusions, Intravenous | Receptor, ErbB-2 - analysis | Trastuzumab | Antimitotic agents | Care and treatment | Clinical trials | Breast cancer | Product development | Antineoplastic agents | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Postoperative pain and quality of life after lobectomy via video-assisted thoracoscopic surgery or anterolateral thoracotomy for early stage lung cancer: a randomised controlled trial
by Bendixen, Morten, PhD and Jørgensen, Ole Dan, PhD and Kronborg, Christian, PhD and Andersen, Claus, PhD and Licht, Peter Bjørn, Prof
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 6, pp. 836 - 844
Summary Background Video-assisted thoracoscopic surgery (VATS) is used increasingly as an alternative to thoracotomy for lobectomy in the treatment of... 
Hematology, Oncology and Palliative Medicine | METAANALYSIS | ONCOLOGY | RESECTION | THORACIC-SURGERY | Pain, Postoperative - etiology | Adenocarcinoma - pathology | Prognosis | Follow-Up Studies | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Carcinoma, Squamous Cell - surgery | Lung Neoplasms - pathology | Male | Thoracotomy - adverse effects | Thoracic Surgery, Video-Assisted - adverse effects | Aged, 80 and over | Adult | Female | Carcinoma, Non-Small-Cell Lung - pathology | Length of Stay | Pneumonectomy - adverse effects | Carcinoma, Non-Small-Cell Lung - surgery | Pain, Postoperative - diagnosis | Denmark | Quality of Life | Lung Neoplasms - surgery | Aged | Neoplasm Staging | Adenocarcinoma - surgery | Pain, Postoperative | Lung cancer, Non-small cell | Analysis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
by Bruix, Jordi, Prof and Takayama, Tadatoshi, Prof and Mazzaferro, Vincenzo, Prof and Chau, Gar-Yang, Prof and Yang, Jiamei, Prof and Kudo, Masatoshi, Prof and Cai, Jianqiang, Prof and Poon, Ronnie T, Prof and Han, Kwang-Hyub, Prof and Tak, Won Young, Prof and Lee, Han Chu, Prof and Song, Tianqiang, MD and Roayaie, Sasan, MD and Bolondi, Luigi, Prof and Lee, Kwan Sik, Prof and Makuuchi, Masatoshi, Prof and Souza, Fabricio, MD and Berre, Marie-Aude Le, MSc and Meinhardt, Gerold, MD and Llovet, Josep M, Prof and STORM Investigators and STORM investigators
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 13, pp. 1344 - 1354
Summary Background There is no standard of care for adjuvant therapy for patients with hepatocellular carcinoma. This trial was designed to assess the efficacy... 
Hematology, Oncology and Palliative Medicine | CLINICAL-PRACTICE GUIDELINES | DIAGNOSIS | LIVER-TRANSPLANTATION | RISK-FACTORS | THERAPY | MANAGEMENT | ONCOLOGY | SAFETY | PREVENTION | RECURRENCE | Catheter Ablation - mortality | South America | Carcinoma, Hepatocellular - mortality | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Hepatectomy - mortality | Antineoplastic Agents - administration & dosage | Protein Kinase Inhibitors - adverse effects | North America | Young Adult | Carcinoma, Hepatocellular - drug therapy | Time Factors | Aged, 80 and over | Liver Neoplasms - pathology | Catheter Ablation - adverse effects | Chemotherapy, Adjuvant | Europe | Risk Factors | Niacinamide - adverse effects | Niacinamide - therapeutic use | Disease Progression | New Zealand | Protein Kinase Inhibitors - administration & dosage | Intention to Treat Analysis | Niacinamide - analogs & derivatives | Liver Neoplasms - mortality | Antineoplastic Agents - adverse effects | Phenylurea Compounds - adverse effects | Adult | Female | Double-Blind Method | Hepatectomy - adverse effects | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Neoplasm Recurrence, Local | Phenylurea Compounds - therapeutic use | Carcinoma, Hepatocellular - surgery | Liver Neoplasms - surgery | Treatment Outcome | Niacinamide - administration & dosage | Disease-Free Survival | Phenylurea Compounds - administration & dosage | Asia | Protein Kinase Inhibitors - therapeutic use | Carcinoma, Hepatocellular - pathology | Aged | Australia | Antimitotic agents | Liver cancer | Medical colleges | Surgery | Liver | Clinical trials | Hepatoma | Antineoplastic agents
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials
by Abe, O and Abe, R and Enomoto, K and Kikuchi, K and Koyama, H and Masuda, H and Nomura, Y and Sakai, K and Sugimachi, K and Tominaga, T and Uchino, J and Yoshida, M and Haybittle, J.L and Davies, C and Harvey, V.J and Holdaway, T.M and Kay, R.G and Mason, B.H and Forbes, J.F and Wilcken, N and Gnant, M and Jakesz, R and Ploner, M and Yosef, H.M.A and Focan, C and Lobelle, J.P and Peek, U and Oates, G.D and Powell, J and Durand, M and Mauriac, L and Di Leo, A and Dolci, S and Piccart, M.J and Masood, M.B and Parker, D and Price, J.J and Hupperets, P.S.G.J and Jackson, S and Ragaz, J and Berry, D and Broadwater, G and Cirrincione, C and Muss, H and Norton, L and Weiss, R.B and Abu-Zahra, H.T and Portnoj, S.M and Baum, M and Cuzick, J and Houghton, J and Riley, D and Mansel, R.E and Gordon, N.H and Davis, H.L and Beatrice, A and Mihura, J and Naja, A and Lehingue, Y and Romestaing, P and Dubois, J.B and Delozier, T and Mace Lesec'h, J and Rambert, P and Petruzelka, L and Pribylova, O and Owen, J.R and Harbeck, N and Jänicke, F and Meisner, C and Meier, P and Howell, A and Ribeiro, G.C and Swindell, R and Burrett, J and Clarke, M and Collins, R and Darby, S and Davies, C and Elphinstone, P and Evans, V and Godwin, J and Gray, R and Harwood, C and Hicks, C and Jackson, D and James, S and MacKinnon, E and McGale, P and McHugh, T and Mead, G and Morris, P and Oulds, J and Peto, R and Taylor, C and Wang, Y and Albano, J and De Oliveira, C.F and Gervásio, H and Gordilho, J and ... and Oxford CTSU and EBCTC and Early Breast Cancer Trialists' Collaborative Group (EBCTCG) and Medicinska fakulteten and Institutionen för strålningsvetenskaper and Onkologi and Umeå universitet
The Lancet, ISSN 0140-6736, 2005, Volume 366, Issue 9503, pp. 2087 - 2106
In early breast cancer, variations in local treatment that substantially affect the risk of locoregional recurrence could also affect long-term breast cancer... 
MEDICINE, GENERAL & INTERNAL | CARE PROCESS SURVEY | HEART-DISEASE | SURGICAL ADJUVANT BREAST | CONTRALATERAL BREAST | CONSERVING SURGERY | POSTOPERATIVE RADIOTHERAPY | LOCOREGIONAL RADIATION-THERAPY | PREMENOPAUSAL WOMEN | STAGE-I | TOTAL MASTECTOMY | Breast Neoplasms - surgery | Humans | Middle Aged | Probability | Cause of Death | Randomized Controlled Trials as Topic | Disease-Free Survival | Breast Neoplasms - radiotherapy | Time Factors | Breast Neoplasms - mortality | Female | Aged | Neoplasm Recurrence, Local - epidemiology | Evaluation | Complications and side effects | Care and treatment | Patient outcomes | Breast cancer | Radiotherapy | Cancer | Relapse | Surgery | Breast | Health aspects | Risk factors | Diseases | Therapy | Side effects | Mortality | Radiology | Health risk assessment | care process survey | heart-disease | stage-1 | postoperative radiotherapy | contralateral breast | premenopausal women | Locoregional radiation therapy | surgical adjuvant breast | total mastectomy | conserving surgery
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights